Nexpoint Asset Management’s Akcea Therapeutics Inc AKCA Stock Holding History

Nexpoint Asset Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-36,953	Closed	-$670K	–	195
2020 Q3	$670K	Buy	+36,953	New	+$524K	0.15%	95

Nexpoint Asset Management's AKCA Position: Q4 2020 in Review

Nexpoint Asset Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 36,953 shares — an estimated $670K sold.

Nexpoint Asset Management first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $670K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Nexpoint Asset Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Nexpoint Asset Management sold 36,953 Akcea Therapeutics Inc shares in Q4 2020, an estimated $670K.
Nexpoint Asset Management first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Nexpoint Asset Management's Akcea Therapeutics Inc position peaked at $670K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Nexpoint Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.